Frequently Asked Questions
The market is segmented based on , By Transplantation Type (Allogeneic Bone marrow Transplantation, Autologous Bone Marrow Transplantation), Disease Indication (Lymphoma, Leukemia, Myeloma, Myelodysplasia, Aplastic Anemia, Sickle cell Anemia, Solid Tumors, Thalassemia, Myeloproliferative Neoplasms, Others), End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers) – Industry Trends and Forecast to 2031.
.
The Global Bone Marrow Market size was valued at USD 541.69 USD Million in 2023.
The Global Bone Marrow Market is projected to grow at a CAGR of 5.4% during the forecast period of 2024 to 2031.
The major players operating in the market include Agendia, Agilent Technologies, Ambrilia Biopharma, Astellas Pharma, DiaDexus, Illumina, QIAGEN, F Hoffmann La Roche, Sanofi, Stryker Corporation, PromoCell GmbH, STEMCELL Technologies, Lonza, AllCells, ATCC, Lifeline Cell Technology, Conversant Bio, HemaCare, Mesoblast, Merck KGaA, Discovery Life Sciences, ReeLabs Pvt. , Gamida Cell.
The market report covers data from the U.S., Canada, Mexico, Germany, France, Spain, Turkey, U.K., Netherlands, Russia, Switzerland, Belgium, Hungary, Italy, Rest of Europe, China, India, Japan, Australia, South Korea, Malaysia, Singapore, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, Rest of Middle East and Africa.
